Today's Daily Dose brings you news about AcelRx Pharma's pain medication DSUVIA getting thumbs up from FDA panel; near-term catalyst of Auris Medical; regulatory nod for Grifols' ID CORE XT kit for molecular red blood cell typing; Iovance' public offering and Tandem's t:slim X2 Insulin Pump approval in Canada.
Original Article: FDA Panel Backs ACRX's Pain Drug, ALL Eyes On EARS, TNDM On Watch